Skip to main content

Advertisement

SpringerLink
Log in

Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

A major problem in treating patients with peritoneal spread from colorectal cancer is that at diagnosis wide peritoneal involvement often precludes all curative attempts. A possible solution is to identify those patients at risk for peritoneal metastases and intervene early to prevent locoregional disease spread before it develops and, thus, to improve outcome.

Methods

We analyzed long-term results from a previous study and compared outcomes in 25 patients with advanced colon cancer considered at high risk for peritoneal spread (pT3/pT4 and mucinous or signet ring cell histology) prospectively included and managed with a proactive surgical approach including target organ resection for peritoneal spread plus hyperthermic intraperitoneal chemotherapy (HIPEC) and in 50 retrospectively well-matched controls who underwent standard surgical resection during the same period and in the same hospital by different surgical teams.

Results

At 48 months after the study closed, peritoneal metastases and local recurrence developed significantly less often in proactively managed patients than in controls (4 vs 28 %) (p < 0.03). Patients in the proactive group also survived longer than control patients (median overall survival 59.5 vs 52 months). Despite similar morbidity, Kaplan–Meier survival curves disclosed significantly longer disease-free and overall survival in the proactive than in the control group (p < 0.05 and <0.04).

Conclusions

In patients with advanced colon cancer at risk for peritoneal recurrence, the proactive surgical approach plus HIPEC seems to achieve good locoregional control preventing peritoneal spread thus improving outcome without increasing morbidity. These advantages merit investigation in a multicentric randomized trial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Glehen O, Kwiatkowski F, Sugarbaker PH et al (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22(16):3284–3292

    Article  CAS  PubMed  Google Scholar 

  2. Esquivel J, Elias D, Baratti D et al (2008) Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 98(4):263–267

    Article  PubMed  Google Scholar 

  3. Elias D, Gilly F, Boutitie F et al (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28(1):63–68

    Article  PubMed  Google Scholar 

  4. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH editor; Peritoneal carcinomatosis: principles of management. Boston Kluwers Academic 359–74

  5. Koh JL, Yan TD, Glenn D et al (2009) Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 16(2):327–333

    Article  PubMed  Google Scholar 

  6. Elias D, Honore C, Dumont F et al (2011) Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 254(2):289–293

    Article  CAS  PubMed  Google Scholar 

  7. Honoré C, Goéré D, Souadka A et al (2013) Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review. Ann Surg Oncol 20(1):183–192

    Article  PubMed  Google Scholar 

  8. Nitsche U, Rosenberg R, Balmert A et al (2012) Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer. Ann Surg 256(5):763–771

    Article  PubMed  Google Scholar 

  9. Sugarbaker PH, Sammartino P, Tentes AA (2012) Proactive management of peritoneal metastases from colorectal cancer: the next logical step toward optimal locoregional control. Colorect Cancer 1:115–123

    Article  Google Scholar 

  10. Sugarbaker PH (2013) The evolution of treatment for peritoneal metastases. Colorect Cancer 2:189–192

    Article  Google Scholar 

  11. Sammartino P, Sibio S, Biacchi D, et al (2012) Prevention of peritoneal metastases from colon cancer in high-risk patients: preliminary results of surgery plus prophylactic HIPEC. Gastroenterol Res Pract.2012

  12. Symonds DA, Vickery AL (1976) Mucinous carcinoma of the colon and rectum. Cancer 37(4):1891–1900

    Article  CAS  PubMed  Google Scholar 

  13. Ogino S, Brahmandam M, Cantor M et al (2006) Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol 19(1):59–68

    Article  CAS  PubMed  Google Scholar 

  14. Mekenkamp LJM, Heesterbeek CJ, Punt CJA et al (2012) Reply letter to: Signet ring cell carcinoma as a potential confounding factor in the analysis of outcomes with colorectal mucinous adenocarcinoma. Eur J Cancer 48:3128–3129

    Article  Google Scholar 

  15. World Health Organization (1979) WHO handbook for reporting results of cancer treatment. WHO, Geneva, Switzerland

  16. Nelson H, Petrelli N, Carlin A et al (2001) Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 18;93(8):583–596

    Article  Google Scholar 

  17. Saxena A, Yan TD, Morris DL (2010) A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis. World J Surg 34(1):70–78

    Article  PubMed  Google Scholar 

  18. Iafrate F, Ciolina M, Sammartino P et al (2012) Peritoneal carcinomatosis: imaging with 64-MDCT and 3 T MRI with diffusion-weighted imaging. Abdom Imaging 37(4):616–627

    Article  CAS  PubMed  Google Scholar 

  19. Catenacci DV, Kozloff M, Kindler HL et al (2011) Personalized colon cancer care in 2010. Semin Oncol 38(2):284–308

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Jayne DG, Fook S, Loi C et al (2002) Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89(12):1545–1550

    Article  CAS  PubMed  Google Scholar 

  21. Elias D, Lefevre JH, Chevalier J et al (2009) Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clinical Oncol 27(5):681–685

    Article  Google Scholar 

  22. Kerscher AG, Chua TC, Gasser M et al (2013) Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades. Br J Cancer 108(7):1432–1439

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Noura S, Ohue M, Shingai T et al (2011) Effects of intraperitoneal chemotherapy with mitomycin C on the prevention of peritoneal recurrence in colorectal cancer patients with positive peritoneal lavage cytology findings. Ann Surg Oncol 18(2):396–404

    Article  PubMed  Google Scholar 

  24. Hompes D, Tiek J, Wolthuis A et al (2012) HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome? Ann Oncol 23(12):3123–3129

    Article  CAS  PubMed  Google Scholar 

  25. Rottoli M, Stocchi L, Dietz DW (2012) T4N0 colon cancer has oncologic outcomes comparable to stage III in a specialized center. Ann Surg Oncol 19(8):2500–2505

    Article  PubMed  Google Scholar 

  26. Stewart C, Hillery S, Havlat M (2006) Serosal involvement in colorectal carcinoma. Histopathology 49(4):435–437

    Article  CAS  PubMed  Google Scholar 

  27. Kojima M, Nakajima K, Ishii G et al (2010) Peritoneal elastic laminal invasion of colorectal cancer: the diagnostic utility and clinicopathologic relationship. Am J Surg Pathol 34(9):1351–1360

    Article  PubMed  Google Scholar 

  28. Winder T, Lenz HJ (2010) Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapy. Oncologist 15(8):836–844

    Article  PubMed Central  PubMed  Google Scholar 

  29. Song W, Wu SJ, He YL et al (2009) Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J 122(13):1486–1491

    PubMed  Google Scholar 

  30. Lemmens VE, Klaver YL, Verwaal VJ et al (2011) Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer 128(11):2717–2725

    Article  CAS  PubMed  Google Scholar 

  31. Numata M, Shiozawa M, Watanabe T et al (2012) The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease. World J Surg Oncol 10:109

    Article  PubMed Central  PubMed  Google Scholar 

  32. Sugarbaker PH (2001) Mucinous colorectal carcinoma. J Surg Oncol 77(4):282–283

    Article  CAS  PubMed  Google Scholar 

  33. Catalano V, Loupakis F, Graziano F et al (2009) Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. Br J Cancer 100(6):881–887

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Lee DW, Han SW, Lee HJ et al (2013) Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy. Br J Cancer 108(10):1978–1984

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Elias D, Goéré D, Dumont F et al (2014) Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases. Eur J Cancer 50(2):332–340

    Article  CAS  PubMed  Google Scholar 

  36. Sammartino P, Sibio S, Accarpio F, et al (2014) Prevention of peritoneal carcinomatosis from colorectal cancer: a critical issue. Ann Surg Mar;259 (3)

  37. Sugarbaker PH (2000) It’s what the surgeon doesn’t see that kills the patient. J Nippon Med Sch 67(1):5–8

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We wish to thank Professor Paul Sugarbaker for his intellectual support in encouraging our research and promoting collaborative efforts toward standardizing proactive management for peritoneal spread in colorectal cancer.

Source support

None

Conflict of interest

We have no conflict of interest to declare.

Author information

Authors and Affiliations

  1. Department of Surgery “Pietro Valdoni”, Azienda Policlinico Umberto I, Sapienza University of Rome, Viale del Policlinico 155, 00155, Rome, Italy

    P. Sammartino, S. Sibio, D. Biacchi, M. Cardi, T. Cornali, B. Sollazzo, J. Maherfouad Atta & A. Di Giorgio

  2. Department of Experimental Medicine and Pathology, Azienda Policlinico Umberto I, Sapienza University of Rome, Viale Del Policlinico 155, Rome, Italy

    P. Mingazzini & M. S. Rosati

Authors
  1. P. Sammartino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Sibio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Biacchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Cardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Mingazzini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. S. Rosati
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. Cornali
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. B. Sollazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. Maherfouad Atta
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A. Di Giorgio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Sammartino.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sammartino, P., Sibio, S., Biacchi, D. et al. Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases. Int J Colorectal Dis 29, 1081–1089 (2014). https://doi.org/10.1007/s00384-014-1929-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-014-1929-4

Keywords

Search

Navigation